Chakrabarty K - Search Results

1

Distinct ocular surface soluble factor profile in human corneal dystrophies.

Shetty R, Naidu JR, Nair AP, Vaidya TA, D'Souza S, Matalia H, Deshpande V, Sethu S, Ghosh A, Chakrabarty K. Shetty R, et al. Among authors: chakrabarty k. Ocul Surf. 2020 Apr;18(2):237-248. doi: 10.1016/j.jtos.2019.11.007. Epub 2019 Nov 19. Ocul Surf. 2020. PMID: 31756391

2

Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants.

Vinekar A, Nair AP, Sinha S, Vaidya T, Chakrabarty K, Shetty R, Ghosh A, Sethu S. Vinekar A, et al. Among authors: chakrabarty k. Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):2. doi: 10.1167/iovs.62.3.2. Invest Ophthalmol Vis Sci. 2021. PMID: 33646290 Free PMC article.

3

Corneal cell therapy: with iPSCs, it is no more a far-sight.

Chakrabarty K, Shetty R, Ghosh A. Chakrabarty K, et al. Stem Cell Res Ther. 2018 Oct 25;9(1):287. doi: 10.1186/s13287-018-1036-5. Stem Cell Res Ther. 2018. PMID: 30359313 Free PMC article. Review.

4

Generation of iPSC line (GLNNFi001-A) from peripheral blood mononuclear cells of a patient with macular corneal dystrophy.

Chakrabarty K, Prashanthi KN, Shetty R, Argulwar S, Jeyabalan N, Ghosh A. Chakrabarty K, et al. Stem Cell Res. 2022 Jul;62:102789. doi: 10.1016/j.scr.2022.102789. Epub 2022 Apr 22. Stem Cell Res. 2022. PMID: 35472829 Free article.

5

Stem cell therapy in coronavirus disease 2019: current evidence and future potential.

Shetty R, Murugeswari P, Chakrabarty K, Jayadev C, Matalia H, Ghosh A, Das D. Shetty R, et al. Among authors: chakrabarty k. Cytotherapy. 2021 Jun;23(6):471-482. doi: 10.1016/j.jcyt.2020.11.001. Epub 2020 Nov 9. Cytotherapy. 2021. PMID: 33257213 Free PMC article. Review.

6

Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019.

Chakrabarty K, Shetty R, Argulwar S, Das D, Ghosh A. Chakrabarty K, et al. Cytotherapy. 2022 Mar;24(3):235-248. doi: 10.1016/j.jcyt.2021.08.003. Epub 2021 Sep 14. Cytotherapy. 2022. PMID: 34656419 Free PMC article. Review.

7

Detailed analysis of the genetic and epigenetic signatures of iPSC-derived mesodiencephalic dopaminergic neurons.

Roessler R, Smallwood SA, Veenvliet JV, Pechlivanoglou P, Peng SP, Chakrabarty K, Groot-Koerkamp MJ, Pasterkamp RJ, Wesseling E, Kelsey G, Boddeke E, Smidt MP, Copray S. Roessler R, et al. Among authors: chakrabarty k. Stem Cell Reports. 2014 Apr 3;2(4):520-33. doi: 10.1016/j.stemcr.2014.03.001. eCollection 2014 Apr 8. Stem Cell Reports. 2014. PMID: 24749075 Free PMC article.

8

Prospective of Ras signaling in stem cells.

Chakrabarty K, Heumann R. Chakrabarty K, et al. Biol Chem. 2008 Jul;389(7):791-8. doi: 10.1515/BC.2008.104. Biol Chem. 2008. PMID: 18627319 Review.

9

Genome wide expression profiling of the mesodiencephalic region identifies novel factors involved in early and late dopaminergic development.

Chakrabarty K, Von Oerthel L, Hellemons A, Clotman F, Espana A, Groot Koerkamp M, Holstege FC, Pasterkamp RJ, Smidt MP. Chakrabarty K, et al. Biol Open. 2012 Aug 15;1(8):693-704. doi: 10.1242/bio.20121230. Epub 2012 May 17. Biol Open. 2012. PMID: 23213462 Free PMC article.

10

Enhancement of dopaminergic properties and protection mediated by neuronal activation of Ras in mouse ventral mesencephalic neurones.

Chakrabarty K, Serchov T, Mann SA, Dietzel ID, Heumann R. Chakrabarty K, et al. Eur J Neurosci. 2007 Apr;25(7):1971-81. doi: 10.1111/j.1460-9568.2007.05457.x. Eur J Neurosci. 2007. PMID: 17439485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page